HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 27.61
+1.31 (4.98%)
At close: Jul 31, 2026
HitGen Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 579.37 | 525.57 | 426.99 | 371.32 | 329.65 | 311.06 |
Revenue Growth | 35.89% | 23.09% | 14.99% | 12.64% | 5.98% | 27.69% |
Gross Profit Gross Profit Growth | 320.06 | 284.98 | 221.44 | 182.87 | 157.16 | 146.27 |
Operating Income Operating Income Growth | 146.89 | 125.56 | 80.23 | 10.22 | -21.21 | -3.11 |
Net Income Net Income Growth | 122.72 | 109.51 | 51.36 | 40.72 | 25.27 | 63.38 |
Earnings Per Share EPS Growth | 0.30 | 0.27 | 0.13 | 0.10 | 0.06 | 0.16 |
EPS Growth | 73.79% | 107.69% | 30.00% | 66.67% | -62.50% | -5.88% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Laboratory Services in China Laboratory Services in China Growth | 380.6 |
Laboratory Services in The UK Laboratory Services in The UK Growth | 151.27 |
Offset of Business Segment Offset of Business Segment Growth | -6.3 |
Total Total Growth | 525.57 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 970.53 | 963.98 | 962.22 | 957.49 | 900.05 | 974.68 |
Total Debt Total Debt Growth | 233.24 | 245.06 | 216.75 | 235.6 | 242.91 | 237.65 |
Net Cash (Debt) Net Cash Growth | 737.28 | 718.91 | 745.47 | 721.89 | 657.14 | 737.03 |
Net Cash Growth | -6.62% | -3.56% | 3.27% | 9.85% | -10.84% | -15.35% |
Net Cash Per Share Net Cash Per Share Growth | 1.81 | 1.77 | 1.89 | 1.77 | 1.56 | 1.86 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 232.57 | 216.35 | 128.01 | 125.21 | 52.74 | 43.5 |
Capital Expenditures CapEx Growth | -178.66 | -160.53 | -71.67 | -53.74 | -87.35 | -139.86 |
Free Cash Flow Free Cash Flow Growth | 53.91 | 55.82 | 56.34 | 71.47 | -34.61 | -96.37 |
Free Cash Flow Growth | -31.04% | -0.94% | -21.16% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 55.24% | 54.22% | 51.86% | 49.25% | 47.67% | 47.02% |
Operating Margin | 25.35% | 23.89% | 18.79% | 2.75% | -6.44% | -1.00% |
Pretax Margin | 23.27% | 23.00% | 14.70% | 9.54% | 3.77% | 17.95% |
Profit Margin | 21.18% | 20.84% | 12.03% | 10.97% | 7.66% | 20.38% |
FCF Margin | 9.30% | 10.62% | 13.20% | 19.25% | -10.50% | -30.98% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.130 | 0.130 | 0.060 | 0.050 | - | 0.050 |
Dividend Per Share Growth | 116.67% | 116.67% | 20.00% | - | - | 0% |
Dividend Yield | 0.47% | 0.56% | 0.49% | 0.34% | - | 0.22% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 91.86 | 85.54 | 95.82 | 147.05 | 213.77 | 148.49 |
Forward PE | 81.21 | 89.33 | 82.80 | 153.74 | 63.80 | 78.61 |
P/FCF Ratio | 205.21 | 167.82 | 87.34 | 83.78 | - | - |
PS Ratio | 19.09 | 17.82 | 11.53 | 16.13 | 16.39 | 30.26 |